Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Egile Nagusiak: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Oxford University Press
2018
|
Antzeko izenburuak
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
nork: Wattanakul, T, et al.
Argitaratua: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
nork: Thanaporn Wattanakul, et al.
Argitaratua: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
nork: Chotsiri, P, et al.
Argitaratua: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
nork: Pukrittayakamee, S, et al.
Argitaratua: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
nork: Saito, M, et al.
Argitaratua: (2018)